ReposiTrak (TRAK) AI Stock Analysis

• Market Cap: $152.54M
• Dividend Yield: 0.57%
• Average Volume (3M): 74.89K
• Price to Earnings (P/E): 22.6
• Beta (1Y): 1.46
• Revenue Growth: 11.05%
• EPS Growth: 18.55%
• Country: US
• Employees: 73
• Sector: Technology
• Sector Strength: 88
• Industry: Software - Application
• EPS (TTM): 0.09
• Shares Outstanding: 18,203,410
• 10 Day Avg. Volume: 93,616
• 30 Day Avg. Volume: 74,886
• PEG Ratio: 2.57
• Price to Book (P/B): 7.25
• Price to Sales (P/S): 15.87
• P/FCF Ratio: 42.70
• Enterprise Value/Market Cap: 0.84
• Enterprise Value/Revenue: 5.43
• Enterprise Value/Gross Profit: 6.38
• Enterprise Value/Ebitda: 14.65
• 1Y Price Target: $16.00
• Price Target Upside: 90.93% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 1
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 67 Neutral
• Price Target: $10.00 ▲(19.33% Upside)
• Action: Downgraded Date: 02/20/26
• Date: Action: Downgraded 02/20/26

The score is supported by strong fundamentals—high margins, solid profitability, and a very low-risk balance sheet—plus a generally positive earnings-call outlook around recurring revenue and capital returns. This is tempered by very weak technicals (clear downtrend and negative momentum) and a valuation that looks more fair than compelling given the modest dividend and recent variability in free-cash-flow growth.

Positive Factors

High Profitability

Sustained very high gross and healthy net margins indicate durable pricing power and a capital-light SaaS model. High margins support reinvestment in product, steady cash returns to shareholders, and buffer margin compression during industry cost shocks over the next 2–6 months.

Conservative Balance Sheet

A very low-leverage, net-cash position provides durable financial flexibility: it funds buybacks/dividends, absorbs cyclical downturns, and supports targeted M&A or capex without raising expensive debt, sustaining strategic optionality over the medium term.

Recurring Revenue & Network Effects

Near-complete conversion to recurring SaaS plus a large Traceability Network and filed IP strengthens retention and expands supplier onboarding incentives. Network effects and patented AI detection create a persistent moat that stabilizes revenue and unit economics long-term.

Negative Factors

High Supplier Data Error Rates

Very high supplier error rates materially raise remediation costs and manual support needs, constraining scalable onboarding and increasing operating expense per customer. Over time this can blunt Traceability margins and slow net-new revenue from this strategic product line.

Slow Traceability Onboarding

A multi-year onboarding timeline delays realization of Traceability revenue and extends payback periods on product investments. Slow adoption reduces near-term growth leverage from the RTN, making scale benefits and network-driven revenue gains more uncertain over the medium term.

Negative Recent FCF Growth

Declining TTM free cash flow growth signals variability in cash conversion despite solid margins. Reduced FCF growth constrains internal funding for continued product development, buybacks or accelerated supplier onboarding without altering capital allocation or raising external capital.

ReposiTrak Business Overview & Revenue Model

Company Description

ReposiTrak, Inc., a software-as-a-service provider, designs, develops, and markets proprietary software products in North America. The company offers ReposiTrak MarketPlace, a supplier discovery and B2B e-commerce solution; ReposiTrak Compliance and Food Safety solutions, which reduces potential regulatory and legal risk from their supply chain partners; and ReposiTrak Supply Chain solutions that enables customers to manage relationships with suppliers. It also provides ScoreTracker, Vendor Managed Inventory, Store Level Ordering and Replenishment, Enterprise Supply Chain Planning, Fresh Market Manager, Audit Management, and ActionManager supply chain solutions to manage inventory, product mix, and labor. In addition, the company offers business-consulting services to suppliers and retailers in the grocery, convenience store, and specialty retail industries, as well as professional consulting services. It primarily serves multi-store retail chains, wholesalers and distributors, and their suppliers. The company was formerly known as Park City Group, Inc. and changed its name to ReposiTrak, Inc. in December 2023. ReposiTrak, Inc. is headquartered in Murray, Utah.

How the Company Makes Money

ReposiTrak generates revenue through a subscription-based model, where clients pay for access to its software platform and services. Key revenue streams include annual subscriptions for compliance and traceability solutions, transaction fees from the processing of product data, and consulting services aimed at helping businesses optimize their supply chain processes. Additionally, partnerships with major retailers and food industry stakeholders enhance revenue opportunities through shared compliance initiatives and data analytics services, allowing ReposiTrak to expand its market reach and strengthen its service offerings.

ReposiTrak Financial Statement Overview

Summary

Strong profitability and business quality (TTM gross margin ~85%, net margin ~31%) with steady revenue growth and an exceptionally conservative balance sheet (minimal leverage). Main offsets are some margin cadence variability and softer recent free-cash-flow growth (TTM FCF growth about -15%) despite generally solid cash conversion.

Income Statement

TRAK shows strong, improving profitability with very high gross margins (TTM (Trailing-Twelve-Months) ~85%) and healthy net margins (~31%). Revenue has grown steadily over the last several annual periods, with a sharp acceleration in TTM growth (reported ~158%), supporting operating leverage and solid earnings power. The main watch-out is some volatility in operating profitability versus the most recent annual period (EBITDA margin lower in TTM than FY2025), suggesting margin cadence can move around period to period.

Balance Sheet

The balance sheet is very conservatively positioned: debt is minimal (TTM debt-to-equity ~0.01) and equity is sizable relative to assets, indicating low financial risk and strong flexibility. Returns on equity are solid and improving (TTM ~14.5% vs ~9–12% in earlier years), consistent with a profitable model without meaningful leverage. A potential downside is that with such low leverage, growth may depend more on internal cash generation rather than balance-sheet-driven expansion.

Cash Flow

Cash generation is generally strong and high-quality: operating cash flow and free cash flow track net income closely (TTM free cash flow is ~1.0x net income), suggesting limited earnings distortion. However, free cash flow growth is negative in TTM (about -15%), and operating cash flow coverage of net income has moderated versus some prior years, pointing to near-term variability in cash conversion despite still-healthy absolute cash flow.

Breakdown	TTM	Jun 2025	Sep 2024	Jun 2023	Jun 2022	Jun 2021
Income Statement
Total Revenue	23.50M	22.61M	20.45M	19.10M	18.05M	21.01M
Gross Profit	19.97M	18.92M	17.04M	15.79M	14.86M	13.10M
EBITDA	8.71M	8.95M	7.61M	7.11M	5.38M	5.41M
Net Income	7.27M	6.98M	5.96M	5.59M	4.00M	4.12M
Balance Sheet
Total Assets	56.31M	55.33M	51.60M	50.58M	49.32M	55.05M
Cash, Cash Equivalents and Short-Term Investments	28.71M	28.57M	25.15M	23.99M	21.46M	24.07M
Total Debt	403.84K	509.97K	545.10K	747.11K	2.97M	6.70M
Total Liabilities	6.59M	5.81M	4.74M	4.70M	6.42M	9.91M
Stockholders Equity	49.72M	49.52M	46.85M	45.88M	42.90M	45.14M
Cash Flow
Free Cash Flow	6.84M	8.40M	6.89M	7.96M	6.05M	5.08M
Operating Cash Flow	6.87M	8.42M	6.96M	8.86M	6.10M	5.40M
Investing Cash Flow	-18.06K	169.00	-100.71K	-903.19K	1.32M	-318.87K
Financing Cash Flow	-6.16M	-5.01M	-5.70M	-5.43M	-10.03M	-1.36M

ReposiTrak Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 8.38
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Positive
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TRAK, the sentiment is Negative. The current price of 8.38 is below the 20-day moving average (MA) of 10.06, below the 50-day MA of 11.32, and below the 200-day MA of 15.84, indicating a bearish trend. The MACD of -0.75 indicates Positive momentum. The RSI at 19.21 is Positive, neither overbought nor oversold. The STOCH value of 1.69 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TRAK.

ReposiTrak Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
TRAK	67 Neutral	$152.54M	22.61	14.60%	0.57%	11.05%	18.55%
MKTW	66 Neutral	$222.17M	1.32	―	14.78%	-19.17%	308.81%
Sector *	61 Neutral	$37.18B	12.37	-10.20%	1.83%	8.50%	-7.62%
EGHT	60 Neutral	$296.75M	-67.41	-3.02%	―	0.25%	92.10%
ONTF	59 Neutral	$337.30M	-10.72	-20.20%	―	-6.23%	28.57%
FRGE	52 Neutral	$617.47M	-9.05	-28.65%	―	16.40%	22.80%
SMRT	51 Neutral	$298.94M	-4.42	-25.48%	―	-24.30%	-181.62%

ReposiTrak Corporate Events

ReposiTrak posts strong Q2 growth and dividend hike

For the second fiscal quarter ended December 31, 2025, ReposiTrak reported a 7% revenue increase to $5.9 million and a 34% jump in operating income to $1.8 million, lifting operating margin to 31%. GAAP net income rose to $1.7 million, with net income to common shareholders up 13% to $1.6 million, or $0.09 per diluted share, while the company closed the quarter holding $28.7 million in cash and no bank debt.

ReposiTrak highlighted patent filings for its new Touchless Traceability solution, which augments its ReposiTrak Traceability Network to automate compliant data records at scale and aims to deepen its competitive moat. The company continued returning capital to investors in the quarter, redeeming preferred shares, repurchasing 79,927 common shares for about $1.1 million and delivering a third consecutive 10% dividend increase, underscoring confidence in its structural profitability and growth in demand for its traceability and compliance offerings.

The most recent analyst rating on (TRAK) stock is a Hold with a $10.00 price target. To see the full list of analyst forecasts on ReposiTrak stock, see the TRAK Stock Forecast page.

ReposiTrak Announces Ongoing Quarterly Cash Dividend Program

On December 19, 2025, ReposiTrak, Inc. declared a quarterly cash dividend of $0.02 per share, equivalent to $0.08 per share on an annualized basis, on its common stock. The dividend will be paid on or about February 13, 2026, to shareholders of record as of December 31, 2025, with subsequent quarterly dividends expected to be paid within 45 days of each fiscal quarter end, signaling an ongoing capital return program that may underscore management’s confidence in the company’s cash generation and financial stability for investors.

The most recent analyst rating on (TRAK) stock is a Buy with a $15.00 price target. To see the full list of analyst forecasts on ReposiTrak stock, see the TRAK Stock Forecast page.

ReposiTrak Announces New Share Repurchase Program

On December 4, 2025, ReposiTrak announced that its Board of Directors approved a new 10B5-1 share repurchase program, allowing the company to buy back up to $2 million of its common stock. This initiative is part of a larger $21 million repurchase program, with $7.6 million still available for repurchase. The 10B5-1 plan is a strategic move to optimize capital allocation, facilitating the repurchase and retirement of common shares, alongside other initiatives like redeeming preferred shares and paying dividends.

The most recent analyst rating on (TRAK) stock is a Buy with a $14.50 price target. To see the full list of analyst forecasts on ReposiTrak stock, see the TRAK Stock Forecast page.

ReposiTrak Holds Annual Stockholders Meeting

On November 19, 2025, ReposiTrak, Inc. held its Annual Meeting of Stockholders where several key proposals were voted on. The election of directors resulted in the re-election of all nominees, and stockholders approved the executive compensation on a non-binding advisory basis. Additionally, it was decided that the advisory vote on executive compensation will occur every three years, and Haynie & Company was ratified as the independent auditor for the fiscal year ending June 30, 2026.

The most recent analyst rating on (TRAK) stock is a Buy with a $16.50 price target. To see the full list of analyst forecasts on ReposiTrak stock, see the TRAK Stock Forecast page.